SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-247783
Filing Date
2022-09-20
Accepted
2022-09-20 17:16:00
Documents
12
Period of Report
2022-09-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d404992d8k.htm   iXBRL 8-K 23997
  Complete submission text file 0001193125-22-247783.txt   148717

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA logc-20220915.xsd EX-101.SCH 2861
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20220915_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20220915_pre.xml EX-101.PRE 11711
6 EXTRACTED XBRL INSTANCE DOCUMENT d404992d8k_htm.xml XML 3471
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 221254462
SIC: 2836 Biological Products, (No Diagnostic Substances)